Nanoform, an innovative nanoparticle medicine enabling company, today announced it has received ISO/IEC 27001:2013 certification for its Information Security Management System (ISMS). The ISMS applies to all information, systems, processes, and people that operate, store, handle, and process Nanoform’s and its clients’ trusted data. It covers the IT services provided to support both Nanoform’s client-facing business functions and internal functions.
Tuukka Haarni, Lead Auditor at Kiwa Inspecta, commented: “The development and implementation of the Nanoform ISMS has been systematic, and there is a well-developed understanding of the requirements of the international standard ISO/IEC 27001:2013 in the organization. Top management commitment to information security is strong, and in the whole company information security is perceived as one of the corner stones for building trust between Nanoform, its clients and its partners.”
Christian Jones, CCO of Nanoform, commented: “As a rapidly growing drug enabling company, we have chosen to implement the ISMS standard in order to benefit from the best practice in the industry. As a proprietary technology provider to the global pharmaceutical industry, we treat information security matters on par with quality control and quality assurance. We are very proud to add this latest world-wide certification and best-practice approach to our global customer offering”.
Nanoform is an innovative nanoparticle medicine enabling company. Nanoform works together with pharma and biotech partners globally to reduce attrition in clinical trials and enhance their molecules’ formulation performance through its nanoforming services. Nanoform’s unique technology provides novel opportunities in many value-enhancing drug delivery applications.